About this trial
Postoperative delirium is a significant and commonly encountered complication in patients undergoing hip surgery, particularly among the elderly. Postoperative delirium is associated with serious consequences, including prolonged intensive care unit stay, increased complication rates, higher mortality risk, and rising healthcare costs.
The incidence of Postoperative delirium after hip fracture surgery has been reported to range between 13% and 55.9%, indicating a substantial clinical burden.
Effective postoperative pain control is critical not only for maintaining quality of life but also for preserving cognitive well-being. In this context, peripheral nerve blocks are frequently used for pain management following hip surgery.
Eligibility criteria
Qualifiers
Patients aged 18-80
ASA I-III risk groups
Undergoing elective hip surgery
Disqualifiers
Preoperative history of delirium, dementia, or major neurological disease
Present cognitive impairment or severe hearing or visual impairment that could affect pain assessment
Development of mechanical ventilation requirement in the intensive care unit; Need for bilateral hip surgery
Failure to provide meaningful analgesia after block application due to surgical pain outside the scope of the block
Trial design
Treatments tested in this trial
- Peripheral nerve block applied
- Only multimodal analgesia applied